Viola Previtali

485 total citations
23 papers, 338 citations indexed

About

Viola Previtali is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Viola Previtali has authored 23 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in Viola Previtali's work include DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Viola Previtali is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Viola Previtali collaborates with scholars based in Denmark, Ireland and Italy. Viola Previtali's co-authors include Mads H. Clausen, Isabel Rozas, Thomas L. Andresen, Anders E. Hansen, Cristina Trujillo, Brendan Twamley, Hussain Ullah, Amir Waseem, Robert J. Baker and Muhammad Khawar Rauf and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Viola Previtali

21 papers receiving 335 citations

Peers

Viola Previtali
Matteo Stefanini Italy
Mallesh Pandrala United States
H. Moriyama Japan
Toshiyuki Seki Japan
Stephanie W. Chang United States
Agnieszka Fedoruk‐Wyszomirska Poland
Romana Masnikosa Serbia
Joshua D. Seitz United States
Virginia del Solar Spain
Matteo Stefanini Italy
Viola Previtali
Citations per year, relative to Viola Previtali Viola Previtali (= 1×) peers Matteo Stefanini

Countries citing papers authored by Viola Previtali

Since Specialization
Citations

This map shows the geographic impact of Viola Previtali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Previtali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Previtali more than expected).

Fields of papers citing papers by Viola Previtali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Previtali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Previtali. The network helps show where Viola Previtali may publish in the future.

Co-authorship network of co-authors of Viola Previtali

This figure shows the co-authorship network connecting the top 25 collaborators of Viola Previtali. A scholar is included among the top collaborators of Viola Previtali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola Previtali. Viola Previtali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Previtali, Viola, et al.. (2025). Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation. RSC Advances. 15(5). 3427–3438. 1 indexed citations
2.
Yang, Zhijie, Jens Preben Morth, Grit Walther, et al.. (2024). Alligamycin A, an antifungal β-lactone spiroketal macrolide from Streptomyces iranensis. Nature Communications. 15(1). 9259–9259. 4 indexed citations
3.
Previtali, Viola, et al.. (2024). New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives. Journal of Medicinal Chemistry. 67(14). 11488–11521. 22 indexed citations
4.
Previtali, Viola, et al.. (2023). Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies. Cancers. 15(6). 1817–1817. 6 indexed citations
5.
Catalano, Federico, Roberto Marotta, Samuel H. Myers, et al.. (2023). Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer. Angewandte Chemie. 135(51).
6.
Catalano, Federico, Roberto Marotta, Samuel H. Myers, et al.. (2023). Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer. Angewandte Chemie International Edition. 62(51). e202312517–e202312517. 4 indexed citations
7.
Previtali, Viola, Samuel H. Myers, Kieran Wynne, et al.. (2023). Preomic profile of BxPC-3 cells after treatment with BRC4. Journal of Proteomics. 288. 104983–104983.
8.
Myers, Samuel H., Marina Veronesi, Viola Previtali, et al.. (2023). An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer. European Journal of Medicinal Chemistry. 265. 116114–116114. 8 indexed citations
9.
Previtali, Viola, et al.. (2022). A Concise Total Synthesis of the Fungal Isoquinoline Alkaloid TMC-120B. Molecules. 27(2). 521–521. 3 indexed citations
10.
Shaaban, Mohamed, Ahmed S. Abdel‐Razek, Viola Previtali, et al.. (2021). Sulochrins and alkaloids from a fennel endophyte Aspergillus sp. FVL2. Natural Product Research. 37(8). 1310–1320. 5 indexed citations
11.
Previtali, Viola, et al.. (2021). Synthesis and evaluation of hydrogen peroxide sensitive tofacitinib prodrugs. SHILAP Revista de lepidopterología. 4. 100019–100019. 2 indexed citations
12.
13.
Previtali, Viola, et al.. (2020). Exploring the Anti-Cancer Mechanism of Novel 3,4′-Substituted Diaryl Guanidinium Derivatives. Pharmaceuticals. 13(12). 485–485. 3 indexed citations
14.
Previtali, Viola, Goar Sánchez‐Sanz, & Cristina Trujillo. (2019). Theoretical Investigation of Cyano‐Chalcogen Dimers and Their Importance in Molecular Recognition. ChemPhysChem. 20(23). 3186–3194. 11 indexed citations
15.
Previtali, Viola, et al.. (2019). Prodrug strategies for targeted therapy triggered by reactive oxygen species. MedChemComm. 10(9). 1531–1549. 85 indexed citations
16.
Ullah, Hussain, Viola Previtali, Brendan Twamley, et al.. (2019). Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines. European Journal of Medicinal Chemistry. 181. 111544–111544. 76 indexed citations
17.
Previtali, Viola, et al.. (2019). Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis. Bioorganic & Medicinal Chemistry. 28(2). 115247–115247. 9 indexed citations
18.
Previtali, Viola, et al.. (2018). Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis. European Journal of Medicinal Chemistry. 156. 738–746. 22 indexed citations
19.
Previtali, Viola, et al.. (2018). Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 61(8). 3503–3515. 55 indexed citations
20.
Previtali, Viola, Cristina Trujillo, Jean-Charles Boisson, et al.. (2017). Development of the first model of a phosphorylated, ATP/Mg2+-containing B-Raf monomer by molecular dynamics simulations: a tool for structure-based design. Physical Chemistry Chemical Physics. 19(46). 31177–31185. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matteo Stefanini Breakdown of academic impact, for papers by Mallesh Pandrala Breakdown of academic impact, for papers by H. Moriyama Breakdown of academic impact, for papers by Toshiyuki Seki Breakdown of academic impact, for papers by Stephanie W. Chang Breakdown of academic impact, for papers by Agnieszka Fedoruk‐Wyszomirska Breakdown of academic impact, for papers by Romana Masnikosa Breakdown of academic impact, for papers by Joshua D. Seitz Breakdown of academic impact, for papers by Virginia del Solar
Rankless by CCL
2026